IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015)

Wee Zhen Ning; Maryam Siti; Yatim J. M.; Kohlabauer Vera K.; Feng Min; Goh Jian Yuan; Yi Bao; Lee Puay Leng; Zhang Songjing; Wang Pan Pan; Lim Elgene; Tam Wai Leong; Cai Yu; Ditzel Henrik J.; Hoon Dave S. B.; Tan Ern Yu; Yu Qiang

首页> 外文期刊>Nature Communications >IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015)

【24h】

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015)

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标（vol 6，8746，2015）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nature Communications》 |2015年第11期|共1页
作者
Wee Zhen Ning; Maryam Siti; Yatim J. M.; Kohlabauer Vera K.; Feng Min; Goh Jian Yuan; Yi Bao; Lee Puay Leng; Zhang Songjing; Wang Pan Pan; Lim Elgene; Tam Wai Leong; Cai Yu; Ditzel Henrik J.; Hoon Dave S. B.; Tan Ern Yu; Yu Qiang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类自然科学总论;
关键词

相似文献

外文文献
中文文献
专利

1. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015) [J] . Wee Zhen Ning, Maryam Siti, Yatim J. M., Nature Communications . 2015,第Nova期

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标（vol 6，8746，2015）
2. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel [J] . Wee Zhen Ning, Yatim Siti Maryam J. M., Kohlbauer Vera K., Nature Communications . 2015,第Nova期

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标
3. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel [J] . Zhen Ning Wee, Siti Maryam J. M. Yatim, Vera K Kohlbauer, Nature Communications . 2015,第2016期

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标
4. Therapeutic ultrasound microbubbles carrying paclitaxel and LyP-1 peptide: Preparation, characterization and application to ultrasonic assisted chemotherapy in breast cancer cells [C] . Yan Fei, Li Xiang, Jin Qiaofeng, 2010 IEEE International Ultrasonics Symposium . 2010

机译：载有紫杉醇和LyP-1肽的治疗性超声微泡：乳腺癌细胞超声辅助化学疗法的制备，表征和应用
5. Enhancement of Gemcitabine and Paclitaxel Uptake and Retention in Metastatic Cancer Cells: A Novel Targeted Combination Delivery Approach to Eliminate Breast Cancer in Blood and Lymph [D] . Yu, Jesse. 2020

机译：吉西他滨和紫杉醇吸收的增强和转移性癌细胞的保留：一种小型靶向组合递送方法，消除血液和淋巴中的乳腺癌
6. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel [O] . Zhen Ning Wee, Siti Maryam J. M. Yatim, Vera K Kohlbauer, -1

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标
7. IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel [O] . Wee, Zhen Ning, Yatim, Siti Maryam J M, Kohlbauer, Vera K, 2015

机译：IRAK1是可促进乳腺癌转移和对紫杉醇耐药的治疗靶标

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel (vol 6, 8746, 2015)

著录项

相似文献

相关主题

期刊订阅